What are the immediate doctor's orders for a patient presenting with a cerebral vascular accident (CVA) bleed?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 29, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Immediate Doctor's Orders for CVA Bleed (Intracerebral Hemorrhage)

For a patient presenting with intracerebral hemorrhage, immediately stabilize blood pressure to systolic 130-150 mmHg, reverse all anticoagulation, admit to neuro-ICU or stroke unit, obtain urgent neurosurgical consultation for cerebellar hemorrhage or hydrocephalus, and stop all antiplatelet agents. 1

Immediate Stabilization (First 15 Minutes)

Airway, Breathing, Circulation

  • Assess and secure airway if GCS ≤8 or signs of impaired ventilation 1
  • Maintain oxygen saturation 93-98% with supplemental oxygen only if needed (do not routinely administer oxygen) 1
  • Ensure adequate ventilation; avoid hyperventilation and excessive PEEP in hypovolemic patients 1

Blood Pressure Management - CRITICAL

  • Target systolic blood pressure 130-150 mmHg immediately 1
  • Use rapid-onset, short-duration IV agents (e.g., labetalol, nicardipine) to facilitate titration 1
  • Avoid aggressive lowering below 130 mmHg systolic - this is harmful 1
  • Place arterial line for continuous BP monitoring 1

Reverse Anticoagulation STAT

For patients on Warfarin (VKA):

  • Administer 4-factor prothrombin complex concentrate (PCC) immediately if INR ≥2.0 1
  • Give IV vitamin K immediately after PCC to prevent later INR rebound 1
  • Fresh frozen plasma is second-line if PCC unavailable 1

For patients on antiplatelet agents (ASA, clopidogrel, dipyridamole):

  • Stop all antiplatelet agents immediately 1
  • Do NOT give platelet transfusions - RCT data shows worse outcomes 1

For patients on DOACs (dabigatran, apixaban, rivaroxaban):

  • Urgent hematology consultation for reversal agent availability 1
  • Stop DOAC immediately 1

Diagnostic Orders (Within 30 Minutes)

Laboratory Studies

  • Complete blood count with platelets 1
  • Coagulation panel: PT/INR, aPTT 1
  • Basic metabolic panel including glucose 1
  • Type and screen 1
  • Arterial blood gas 1

Imaging

  • Non-contrast head CT already obtained for diagnosis
  • CT angiography if concern for underlying vascular malformation or spot sign 1

Admission and Consultation Orders

Admission Location

  • Admit to stroke unit or neuro-intensive care unit 1
  • Continuous cardiac monitoring 1
  • Continuous blood pressure monitoring via arterial line 1

Urgent Neurosurgical Consultation - MANDATORY for:

  • Any cerebellar hemorrhage, especially with altered consciousness or brainstem symptoms 1
  • Acute hydrocephalus requiring external ventricular drain (EVD) 1
  • Supratentorial ICH with GCS 9-12 (may benefit from early surgery) 1
  • Consider for decompressive craniectomy candidates 1

Monitoring Orders

Vital Signs

  • Continuous arterial blood pressure monitoring 1
  • Neurological checks every 1 hour (GCS, pupil exam, focal deficits) 1
  • Core temperature monitoring (bladder or esophageal probe); maintain normothermia 36-37°C 1

Seizure Management

  • Do NOT give prophylactic anticonvulsants 1
  • If seizure occurs: load with levetiracetam 1g IV or phenytoin 20 mg/kg IV (max 2g) 1

Supportive Care Orders

Glucose Management

  • Check blood glucose every 4 hours
  • Target glucose 6-10 mmol/L (108-180 mg/dL) 1

Temperature

  • Maintain normothermia; actively warm if hypothermic 1
  • Avoid hyperthermia 1

DVT Prophylaxis

  • Intermittent pneumatic compression devices immediately 2
  • Hold pharmacologic anticoagulation until bleeding risk assessed 1

Gastric Protection

  • Nasogastric tube if altered consciousness 1
  • Proton pump inhibitor 1

Critical Pitfalls to Avoid

  • Never give recombinant Factor VIIa outside clinical trials - increases thrombotic risk without clinical benefit 1
  • Never give platelet transfusions for antiplatelet-associated ICH - worsens outcomes 1
  • Never delay neurosurgical consultation for cerebellar hemorrhage - can rapidly deteriorate 1
  • Defer DNR/palliative care decisions for 24-48 hours to assess response to therapy 1
  • Do not restart anticoagulation acutely - requires case-by-case assessment with stroke/cardiology/hematology consultation 1

Goals of Care Discussion

  • Establish goals with patient/substitute decision-maker within 24-48 hours 1
  • Reassess DNR status after 24-48 hours if initially placed 1
  • DNR patients should still receive all appropriate medical/surgical interventions unless explicitly indicated otherwise 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Cerebrovascular Accident (CVA) Bleed Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.